AAAAAA
Results:
1-19
|
Results: 19
Authors:
KHURI FR
FOSSELLA FV
LEE JS
MURPHY WK
SHIN DM
MARKOWITZ AB
GLISSON BS
Citation: Fr. Khuri et al., PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/, Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245
Authors:
LEE JS
PISTERS KMW
KOMAKI R
GLISSON BS
PEREZSOLER R
KHURI FR
DELCLOS ME
FOSSELLA FV
Citation: Js. Lee et al., THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/, Annals of oncology, 9, 1998, pp. 660-660
Authors:
SHIN DM
GLISSON BS
KHURI FR
GINSBERG L
PAPADIMITRAKOPOULOU V
LEE JJ
LAWHORN K
GILLENWATER AM
ANG KK
CLAYMAN GL
CALLENDER DL
HONG WK
LIPPMAN SM
Citation: Dm. Shin et al., PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
Authors:
LEE JS
KOMAKI R
FOSSELLA FV
GLISSON BS
HONG WK
COX JD
Citation: Js. Lee et al., A PILOT TRIAL OF HYPERFRACTIONATED THORACIC RADIATION-THERAPY WITH CONCURRENT CISPLATIN AND ORAL ETOPOSIDE FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT, International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 479-486
Authors:
ROTH JA
SWISHER SG
MERRITT JA
LAWRENCE DD
KEMP BL
CARRASCO CH
ELNAGGAR AK
FOSSELLA FV
GLISSON BS
HONG WK
KHURL FR
KURIE JM
NESBITT JC
PISTERS K
PUTNAM JB
SCHRUMP DS
SHIN DM
WALSH GL
Citation: Ja. Roth et al., GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT, Seminars in oncology, 25(3), 1998, pp. 33-37
Authors:
SHIN DM
GLISSON BS
KHURI FR
HONG WK
LIPPMAN SM
Citation: Dm. Shin et al., ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Seminars in oncology, 25(2), 1998, pp. 40-44
Authors:
ROTH JA
SWISHER SG
LAWRENCE DD
KEMP BL
CARRASCO CH
ELNAGGAR AK
FOSSELA FV
GLISSON BS
HONG WK
KHURI FR
KURIE JM
NESBITT JC
PISTERS K
PUTNAM JB
SCHRUMP DS
SHIN DM
WALSH GL
Citation: Ja. Roth et al., LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER, British Journal of Cancer, 78(2), 1998, pp. 142-142
Authors:
GLISSON BS
HONG WK
Citation: Bs. Glisson et Wk. Hong, SURVIVAL AFTER TREATMENT OF SMALL-CELL LUNG-CANCER - AN ENDLESS UPHILL BATTLE, Journal of the National Cancer Institute, 89(23), 1997, pp. 1745-1747
Authors:
SHIN DM
GLISSON BS
KHURI FR
GINSBERG L
LAWHORN K
HONG WK
LIPPMAN SM
Citation: Dm. Shin et al., RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Seminars in oncology, 24(6), 1997, pp. 33-37
Authors:
LEE JS
PISTERS KMW
KOMAKI R
GLISSON BS
KHURI FR
SCHEA R
FOSSELLA FV
Citation: Js. Lee et al., PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/, Seminars in oncology, 24(4), 1997, pp. 52-55
Authors:
GEARA FB
GLISSON BS
SANGUINETI G
TUCKER SL
GARDEN AS
ANG KK
LIPPMAN SM
CLAYMAN GL
GOEPFERT H
PETERS LJ
HONG WK
Citation: Fb. Geara et al., INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA - RESULTS OF AMATCHED COHORT STUDY, Cancer, 79(7), 1997, pp. 1279-1286
Authors:
GLISSON BS
HONG WK
Citation: Bs. Glisson et Wk. Hong, PRIMARY CHEMOTHERAPY OF ADVANCED HEAD AND NECK-CANCER - WHERE DO WE GO FROM HERE, Journal of the National Cancer Institute, 88(9), 1996, pp. 567-568
Authors:
PEREZSOLER R
FOSSELLA FV
GLISSON BS
LEE JS
MURPHY WK
SHIN DM
KEMP BL
LEE JJ
KANE J
ROBINSON RA
LIPPMAN SM
KURIE JM
HUBER MH
RABER MN
HONG WK
Citation: R. Perezsoler et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, Journal of clinical oncology, 14(2), 1996, pp. 503-513
Authors:
PEREZSOLER R
GLISSON BS
LEE JS
FOSSELLA FV
MURPHY WK
SHIN DM
HONG WK
Citation: R. Perezsoler et al., TREATMENT OF PATIENTS WITH SMALL-CELL LUNG CANCER REFRACTORY TO ETOPOSIDE AND CISPLATIN WITH THE TOPOISOMERASE-I POISON TOPOTECAN, Journal of clinical oncology, 14(10), 1996, pp. 2785-2790
Authors:
GARDEN AS
LIPPMAN SM
MORRISON WH
GLISSON BS
ANG KK
GEARA F
HONG WK
PETERS LJ
Citation: As. Garden et al., DOES INDUCTION CHEMOTHERAPY HAVE A ROLE IN THE MANAGEMENT OF NASOPHARYNGEAL CARCINOMA - RESULTS OF TREATMENT IN THE ERA OF COMPUTERIZED-TOMOGRAPHY, International journal of radiation oncology, biology, physics, 36(5), 1996, pp. 1005-1012
Authors:
PEREZSOLER R
FOSSELLA FV
MURPHY WK
GLISSON BS
LEE JS
HONG WK
Citation: R. Perezsoler et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE LUNG PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 1076-1076
Authors:
KOMAKI R
SHIN DM
GLISSON BS
FOSSELLA FV
MURPHY WK
GARDEN AS
OSWALD MJ
HONG WK
ROTH JA
PETERS LJ
HOLOYE PV
ELLERBROEK N
Citation: R. Komaki et al., INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 31(4), 1995, pp. 807-811
Authors:
FISK B
IOANNIDES CG
AGGARWAL S
WHARTON JT
OBRIAN CA
RESTIFO N
GLISSON BS
Citation: B. Fisk et al., ENHANCED EXPRESSION OF HLA-A,B,C AND INDUCIBILITY OF TAP-1, TAP-2, AND HLA-A,B,C BY INTERFERON-GAMMA IN A MULTIDRUG-RESISTANT SMALL-CELL LUNG-CANCER LINE, Lymphokine and cytokine research, 13(2), 1994, pp. 125-131
Authors:
LIPPMAN SM
GLISSON BS
KAVANAGH JJ
LOTAN R
HONG WK
PAREDESESPINOZA M
HITTELMAN WN
HOLDENER EE
KRAKOFF IH
Citation: Sm. Lippman et al., RETINOIC ACID AND INTERFERON COMBINATION STUDIES IN HUMAN CANCER, European journal of cancer, 29A, 1993, pp. 9-13
Risultati:
1-19
|